These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36572153)

  • 1. NS2 is a key determinant of compatibility in reassortant avian influenza virus with heterologous H7N9-derived NS segment.
    Liu YC; Liao GR; Tsai AY; Tseng CY; Kuan CY; Tsai RS; Albrecht RA; Kuo RL; Cheng IC; Liang WT; Ou SC; Hsu WL
    Virus Res; 2023 Jan; 324():199028. PubMed ID: 36572153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
    Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
    J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
    Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Origin of Internal Genes Contributes to the Replication and Transmission Fitness of H7N9 Avian Influenza Virus.
    James J; Bhat S; Walsh SK; Karunarathna TK; Sadeyen JR; Chang P; Sealy JE; Mahmood S; Mollett BC; Slomka MJ; Brookes SM; Iqbal M
    J Virol; 2022 Nov; 96(22):e0129022. PubMed ID: 36342296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Polymerase Activity Attributed to PA Drives the Acquisition of the PB2 E627K Mutation of H7N9 Avian Influenza Virus in Mammals.
    Liang L; Jiang L; Li J; Zhao Q; Wang J; He X; Huang S; Wang Q; Zhao Y; Wang G; Sun N; Deng G; Shi J; Tian G; Zeng X; Jiang Y; Liu L; Liu J; Chen P; Bu Z; Kawaoka Y; Chen H; Li C
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue.
    Knepper J; Schierhorn KL; Becher A; Budt M; Tönnies M; Bauer TT; Schneider P; Neudecker J; Rückert JC; Gruber AD; Suttorp N; Schweiger B; Hippenstiel S; Hocke AC; Wolff T
    mBio; 2013 Oct; 4(5):e00601-13. PubMed ID: 24105764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avian influenza A virus H7N9 in China, a role reversal from reassortment receptor to the donator.
    He J; Hou S; Xiong C; Hu L; Gong L; Yu J; Zhou X; Chen Q; Yuan Y; He L; Zhu M; Li W; Shi Y; Sun Y; Pan H; Su B; Lu Y; Wu J
    J Med Virol; 2023 Jan; 95(1):e28392. PubMed ID: 36484390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A Virus.
    Yu Y; Wang X; Jin T; Wang H; Si W; Yang H; Wu J; Yan Y; Liu G; Sang X; Wu X; Gao Y; Xia X; Yu X; Pan J; Gao GF; Zhou J
    J Virol; 2015 Sep; 89(17):8806-15. PubMed ID: 26085150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Reassortment Analysis of Influenza A H7N9 Viruses Circulating in China during 2013-2019.
    He D; Wang X; Wu H; Wang X; Yan Y; Li Y; Zhan T; Hao X; Hu J; Hu S; Liu X; Ding C; Su S; Gu M; Liu X
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
    Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
    Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection of Chickens with H9N2 and H7N9 Avian Influenza Viruses Leads to Emergence of Reassortant H9N9 Virus with Increased Fitness for Poultry and a Zoonotic Potential.
    Bhat S; James J; Sadeyen JR; Mahmood S; Everest HJ; Chang P; Walsh SK; Byrne AMP; Mollett B; Lean F; Sealy JE; Shelton H; Slomka MJ; Brookes SM; Iqbal M
    J Virol; 2022 Mar; 96(5):e0185621. PubMed ID: 35019727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impacts of Reassortant Avian Influenza H5N2 Virus NS1 Proteins on Viral Compatibility and Regulation of Immune Responses.
    Wang WC; Kuan CY; Tseng YJ; Chang CH; Liu YC; Chang YC; Hsu YC; Hsieh MK; Ou SC; Hsu WL
    Front Microbiol; 2020; 11():280. PubMed ID: 32226416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant NS1 protein from H5N2 avian influenza virus suppresses PKR activation and promotes replication and virulence in mammals.
    Chung YT; Kuan CY; Liao GR; Albrecht RA; Tseng YY; Hsu YC; Ou SC; Hsu WL
    Emerg Microbes Infect; 2022 Dec; 11(1):2291-2303. PubMed ID: 35979918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin.
    Xu Y; Peng R; Zhang W; Qi J; Song H; Liu S; Wang H; Wang M; Xiao H; Fu L; Fan Z; Bi Y; Yan J; Shi Y; Gao GF
    Cell Rep; 2019 Nov; 29(8):2217-2228.e5. PubMed ID: 31747596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus Adaptation Following Experimental Infection of Chickens with a Domestic Duck Low Pathogenic Avian Influenza Isolate from the 2017 USA H7N9 Outbreak Identifies Polymorphic Mutations in Multiple Gene Segments.
    Chrzastek K; Segovia K; Torchetti M; Killian ML; Pantin-Jackwood M; Kapczynski DR
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.
    Josset L; Zeng H; Kelly SM; Tumpey TM; Katze MG
    mBio; 2014 Feb; 5(1):e01102-13. PubMed ID: 24496798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of H7N9 and H9N2 influenza infections in mouse model unravels the importance of early innate immune response in host protection.
    Zhu C; Zhang M; Fu W; He Y; Yang Y; Zhang L; Yuan S; Jiang L; Xu J; Zhang X
    Front Cell Infect Microbiol; 2022; 12():941078. PubMed ID: 36034707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
    Chang P; Lukosaityte D; Sealy JE; Rijal P; Sadeyen JR; Bhat S; Crossley S; Daines R; Huang KA; Townsend AR; Iqbal M
    J Virol; 2023 Jan; 97(1):e0143122. PubMed ID: 36541801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Genetic Variation on H7N9 Avian Influenza Virus Pathogenicity.
    Huang SW; Wang SF
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33126529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.